Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s):  QNTM

Healthcare Biotechnology
Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.


CSE:QNTM - Post by User

Quantum BioPharma Ltd > UHN trillium
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(41)
•••
Comment by JAKPUG4LIFEon Nov 02, 2021 12:57pm
30 Views
Post# 34077980

RE:RE:RE:UHN trillium

RE:RE:RE:UHN trillium Yet on the biggest facility, yet on cannabis, yet on biotech, yet on pea, yet on shareholder value, yet on all failed loi's, yet on an AD apology for lies and misdirection' yet on you stfu. Stay in your facebook group where only you and your few minions post the same dribble
DavidRosenberg wrote:
Mil_Man54 wrote: Rosenberg is still trying to associate FSD with actaul successful companies who actually follow through on their plan.....you're pathetic Rose3nberg....give it up pumper....FSD is no where in the same league as Trillium!!!!



Nowhere in the same league.... YET , Yet is the keyword. Hopim levels have been renewed aftering conducting more research that FSD Pharma and UHN Network and Lucid will be conducting clinical trials in 2022 for TOTAL BRAIN HEALTH !! How awesome is that!


<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities